Authors: DALAY N YASASEVER V CAMLICA H KARALOGLU D DINCER M

Citation: N. Dalay et al., SERUM C-ERB B2 LEVELS AND BREAST-CANCER, The FASEB journal, 11(3), 1997, pp. 2455-2455

Authors: YASASEVER V DINCER M CAMLICA H KARALOGLU D DALAY N

Citation: V. Yasasever et al., UTILITY OF CA-15-3 AND CEA IN MONITORING BREAST-CANCER PATIENTS WITH BONE METASTASES - SPECIAL EMPHASIS ON SPIKING PHENOMENA, Clinical biochemistry, 30(1), 1997, pp. 53-56

Authors: YASASEVER V KARALOGLU D KIZIR A CAMLICA H DALAY N

Citation: V. Yasasever et al., EVALUATION OF SERUM TUMOR-MARKERS IN GASTROINTESTINAL-TRACT TUMORS, Journal of tumor marker oncology, 11(3), 1996, pp. 29-33

Authors: KARALOGLU D YASASEVER V KIZIR A DALAY N

Citation: D. Karaloglu et al., SERUM LEVELS OF MUTANT P53 PROTEIN IN CANCER, Journal of experimental & clinical cancer research, 15(4), 1996, pp. 335-339

Authors: YASASEVER V DINCER M KARALOGLU D CAMLICA H DALAY N

Citation: V. Yasasever et al., SERUM C-ERBB-2 NEU - IS A COMMON TUMOR-MARKER, Immunology, 89, 1996, pp. 106-106

Authors: ONAT H INANC S KARALOGLU D ERTURK N DALAY N YASASEVER V

Citation: H. Onat et al., ACUTE COAGULATION CHANGES DURING CYTOTOXIC CHEMOTHERAPY, Journal of experimental & clinical cancer research, 13(1), 1994, pp. 89-92